1 reports of this reaction
4.8% of all ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE reports
#3 most reported adverse reaction
CHROMATURIA is the #3 most commonly reported adverse reaction for ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE, manufactured by KROGER COMPANY. There are 1 FDA adverse event reports linking ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE to CHROMATURIA. This represents approximately 4.8% of all 21 adverse event reports for this drug.
Patients taking ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE who experience chromaturia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CHROMATURIA is moderately reported among ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE users, representing a notable but not dominant share of adverse events.
In addition to chromaturia, the following adverse reactions have been reported for ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE:
The following drugs have also been linked to chromaturia in FDA adverse event reports:
CHROMATURIA has been reported as an adverse event in 1 FDA reports for ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CHROMATURIA accounts for approximately 4.8% of all adverse event reports for ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE, making it one of the most commonly reported side effect.
If you experience chromaturia while taking ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.